STRATUS: A Phase II Study of Abituzumab in Patients With Systemic Sclerosis-associated Interstitial Lung Disease.
Zsuzsanna H McMahanDonald P TashkinAthol U WellsJames R SeiboldStephen WaxCristina Vazquez-MateoPatricia Fleuranceau-MorelDoris DamianChristopher P DentonPublished in: The Journal of rheumatology (2020)
Further investigation of abituzumab for treatment of SSc-ILD is required.